Market News

Organovo Holdings, Inc. (ONVO) Reaches $1.23 1 Year Low; Eaton Vance Senior Floating Rate Trust (EFR) Has 1.5 Sentiment

The stock of Organovo Holdings, Inc. (NASDAQ:ONVO) hit a new 52-week low and has $1.14 target or 7.00% below today’s $1.23 share price. The 9 months bearish chart indicates high risk for the $131.52M company. The 1-year low was reported on Feb, 10 by Barchart.com. If the $1.14 price target is reached, the company will be worth $9.21M less. The stock decreased 6.82% or $0.09 during the last trading session, reaching $1.23. About 5.87 million shares traded or 324.18% up from the average. Organovo Holdings, Inc. (NASDAQ:ONVO) has risen 12.50% since February 10, 2017 and is uptrending. It has underperformed by 4.20% the S&P500.

The stock increased 0.49% or $0.07 during the last trading session, reaching $14.27. About 345,179 shares traded or 135.99% up from the average. Eaton Vance Senior Floating-Rate Trust (EFR) has risen 14.61% since February 10, 2017 and is uptrending. It has underperformed by 2.09% the S&P500.

Investors sentiment decreased to 1.53 in Q3 2017. Its down 0.02, from 1.55 in 2017Q2. It fall, as 11 investors sold Organovo Holdings, Inc. shares while 19 reduced holdings. 11 funds opened positions while 35 raised stakes. 24.05 million shares or 7.12% more from 22.45 million shares in 2017Q2 were reported. Next Finance Inc has invested 0% of its portfolio in Organovo Holdings, Inc. (NASDAQ:ONVO). Carroll Fincl holds 0% of its portfolio in Organovo Holdings, Inc. (NASDAQ:ONVO) for 1,000 shares. Schwab Charles Invest Management holds 0% of its portfolio in Organovo Holdings, Inc. (NASDAQ:ONVO) for 412,638 shares. Amer Interest Grp Inc Incorporated stated it has 0% in Organovo Holdings, Inc. (NASDAQ:ONVO). American Finance Gp reported 251,500 shares or 0.06% of all its holdings. Balyasny Asset Mgmt Lc reported 26,300 shares. State Bank Of Ny Mellon Corporation reported 0% in Organovo Holdings, Inc. (NASDAQ:ONVO). Rhumbline Advisers, Massachusetts-based fund reported 112,124 shares. Citadel Ltd Llc has 0% invested in Organovo Holdings, Inc. (NASDAQ:ONVO). Granite Invest Prtn Ltd Liability Com owns 143,836 shares or 0.02% of their US portfolio. Tortoise Investment Ltd Liability Company accumulated 360 shares or 0% of the stock. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0% of its portfolio in Organovo Holdings, Inc. (NASDAQ:ONVO). Commonwealth Equity Svcs, Massachusetts-based fund reported 17,966 shares. 372,261 were accumulated by Morgan Stanley. First Republic Inv Incorporated invested in 114,520 shares.

Organovo Holdings, Inc., an early commercial stage company, creates and creates functional and three-dimensional human tissues for use in medical research and therapeutic applications. The company has market cap of $131.52 million. The firm develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic, and other partners. It currently has negative earnings. The Company’s 3D human tissues could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs.

White Pine Capital Llc holds 6.63% of its portfolio in Eaton Vance Senior Floating-Rate Trust for 175,593 shares. Restructuring Capital Associates Lp owns 264,843 shares or 3.92% of their US portfolio. Moreover, Comerica Securities Inc has 0.28% invested in the company for 133,060 shares. The Massachusetts-based Aureus Asset Management Llc has invested 0.15% in the stock. Twin Focus Capital Partners Llc, a Massachusetts-based fund reported 14,000 shares.

Leave a Reply

Your email address will not be published. Required fields are marked *